Taro Pharmaceuticals USA, Inc.

NY · United States · Reporting entity ID 100000005687

Total reported 2019–2025

$22.1M

#298 of 2,960 reporting companies — 0% of all reported industry payments

$68K in general payments across 727 records, plus $22.1M in research funding across 2,479 records.

How it breaks down

General payments $68,053

Research funding $22,063,890

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.